peginterferon alfa造句

例句与造句

1. Peginterferon alfa-2a is a long acting interferon.
2. The current recommended treatment for patients with hepatitis C is ribavirin combined with peginterferon alfa, which Schering sells as Peg-Intron.
3. However, the 1960s Soviet technology of using low dose Interferon alfa 2b for influenza ( see also Peginterferon alfa-2b ) is interesting.
4. It occurred in half of the patients who received boceprevir and by about a third of the patients taking peginterferon alfa-2b plus ribavirin at the standard dose.
5. The standard current therapy for chronic cases _ a combination of a different type of interferon, peginterferon alfa, and the antiviral drug ribavirin _ has a success rate of about 55 percent.
6. It's difficult to find peginterferon alfa in a sentence. 用peginterferon alfa造句挺难的
7. An SVR after 24 weeks off therapy of 75 % was achieved in the group treated for 48 weeks with four weeks of lead-in therapy with peginterferon alfa-2b plus ribavirin followed by the addition of boceprivir.
8. "' Pegetron Redipen "'( or Pegetron Redipen ) is a needle-based injector medical device ( drug delivery device ) that uses a dual chamber cartridge and is the first and only pen delivery system the U . S . Food and Drug Administration approved for administering pegylated interferon ( Peginterferon alfa-2b ) therapy for chronic hepatitis C . This delivery device is an easy-to-use alternative to traditional vial and syringe.
9. The phase-II trial compared three different regimens : four weeks of peginterferon alfa-2b ( 1.5 micrograms / kg once weekly ) plus ribavirin ( 800 to 1400 mg daily based on patient weight ) followed by boceprevir ( 800 mg three times a day in addition to peginterferon and ribavirin ) for 24 weeks or 44 weeks; boceprevir in combination with peginterferon alfa-2b plus ribavirin as above for 28 or 48 weeks ( triple therapy ); and peginterferon alfa-2b plus low-dose ribavirin ( 400 to 1000 mg / day ) and boceprevir for 48 weeks.
10. The phase-II trial compared three different regimens : four weeks of peginterferon alfa-2b ( 1.5 micrograms / kg once weekly ) plus ribavirin ( 800 to 1400 mg daily based on patient weight ) followed by boceprevir ( 800 mg three times a day in addition to peginterferon and ribavirin ) for 24 weeks or 44 weeks; boceprevir in combination with peginterferon alfa-2b plus ribavirin as above for 28 or 48 weeks ( triple therapy ); and peginterferon alfa-2b plus low-dose ribavirin ( 400 to 1000 mg / day ) and boceprevir for 48 weeks.
11. The phase-II trial compared three different regimens : four weeks of peginterferon alfa-2b ( 1.5 micrograms / kg once weekly ) plus ribavirin ( 800 to 1400 mg daily based on patient weight ) followed by boceprevir ( 800 mg three times a day in addition to peginterferon and ribavirin ) for 24 weeks or 44 weeks; boceprevir in combination with peginterferon alfa-2b plus ribavirin as above for 28 or 48 weeks ( triple therapy ); and peginterferon alfa-2b plus low-dose ribavirin ( 400 to 1000 mg / day ) and boceprevir for 48 weeks.